Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif. -- Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will [...]

New, Easy-to-Use, Compact, Ion Chromatography System Simplifies Water Analysis

Thermo Scientific Dionex Easion Ion Chromatography System makes everyday ion analysis simpler, while reducing total cost of ownership and need for maintenance SUNNYVALE, Calif. -- Small environmental and academic teaching laboratories specializing in water analysis can benefit from simpler setup and operation and improved quality with a new, compact ion chromatography (IC) system that can bring an [...]

MOBILion Closes $35M Series B Financing Round

aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion's SLIM technology for biotherapeutics characterization and novel biomarker discovery. Chadds Fords, PA. -- MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35 million Series B funding round. The oversubscribed round was [...]

PerkinElmer Enhances Hand Sanitizer Analyzer to Detect Methanol in 30 Seconds or Less

nstrument also tests ethanol and isopropanol concentrations to confirm product efficacy WALTHAM, Mass.-- PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. Recent warnings and recalls [...]

REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research

Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. VIROCLINICS-DDL is the global leader in clinical trial management services, focused on viral targets such as influenza, COVID-19, RSV, HBV and Polio. REPROCELL will provide sample processing services in Japan to VIROCLINICS-DDL and will support [...]

IsoPlexis Adds Partnership to Advance COVID-19 Vaccine Development

BRANFORD, Conn. -- IsoPlexis, the leader in single-cell functional proteomics, today announced a partnership with the Division of Infectious Diseases, Department of Medicine at Columbia University, IsoPlexis' Single-Cell Secretome immune profiling solutions will be used to study cellular drivers of durable and protective immune response to COVID-19. (PRNewsfoto/IsoPlexis) T cell and other immune cell polyfunctional cytokine responses on IsoPlexis' platform have previously [...]

PARTNERSHIP WITH CARCINOTECH TO ADVANCE 3D-BIOPRINTING TECHNOLOGY FOR CANCER RESEARCH

CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer [...]

PARTNERSHIP WITH CARCINOTECH TO ADVANCE 3D-BIOPRINTING TECHNOLOGY FOR CANCER RESEARCH

CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer [...]

HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder

TUCSON, Ariz.  -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder). On August 13, 2020, BioSpyder filed a lawsuit seeking a declaration that it does not infringe HTG’s U.S. Patent No. 8,741,564 (the ’564 patent). In [...]

SERSTECH AB: Serstech receives EU funding for CBRN project

A consortium of public and private organizations, of which Serstech is part, has been granted funding from the European Commission. The project aims to develop technologies, based on Raman and SERS (Surface Enhanced Raman Spectroscopy), to detect and identify chemical warfare agents and toxic industrial compounds in liquid and gas form. Serstech will supply modified [...]

Access IBO on Knowledge Center